Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous
- PMID: 16140249
- DOI: 10.1016/j.ajo.2005.04.017
Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous
Abstract
Purpose: To investigate the effect of exogenous plasmin administration on the activity of endogenous matrix metalloproteinase-2 (MMP-2) in rabbit and human vitreous.
Design: Experimental animal study and interventional case series.
Methods: Human plasmin was injected into rabbit eyes. The active/pro-MMP-2 ratio in vitreous samples was calculated using the gelatin zymography. Scanning electron microscopy (SEM) was performed to observe the retinal surface. To evaluate the time course of MMP-2 activity, vitreous samples were collected after the injection of 0.5 IU of plasmin, and the active/pro-MMP-2 ratio was calculated in the same manner. Immunohistochemical analysis was performed to confirm the presence of MT1-MMP in the rabbit eye. Human vitreous samples obtained from vitreous surgeries were also used for similar studies.
Results: The active/pro-MMP-2 ratios in the vitreous after the injection of 0.25 IU or 0.5 IU of plasmin were significantly higher than that of the control (P < .05). SEM demonstrated that plasmin-treated eyes showed a smooth retinal surface that was dose-dependent. Time course evaluation of the active/pro-MMP-2 ratio in the vitreous after the administration of 0.5 IU of plasmin found a significant difference between the 5 and 15 minutes data points compared with that seen for the control. Immunohistochemical study revealed the presence of MT1-MMP in the inner retina. In human samples, the active/pro-MMP-2 ratio after the plasmin injection was significantly higher than the ratio observed before injection.
Conclusions: Our results suggested that activation of endogenous MMP-2 by exogenous plasmin is associated with the induction of posterior vitreous detachment.
Comment in
-
Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.Am J Ophthalmol. 2006 Apr;141(4):784-5; author reply 785. doi: 10.1016/j.ajo.2005.12.034. Am J Ophthalmol. 2006. PMID: 16564844 No abstract available.
Similar articles
-
Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.Am J Ophthalmol. 2006 Apr;141(4):784-5; author reply 785. doi: 10.1016/j.ajo.2005.12.034. Am J Ophthalmol. 2006. PMID: 16564844 No abstract available.
-
Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.Ophthalmology. 2004 Feb;111(2):231-7. doi: 10.1016/j.ophtha.2003.06.001. Ophthalmology. 2004. PMID: 15019368
-
[An experimental study on dissolving and detaching vitreoretinal interface with enzymes].Zhonghua Yan Ke Za Zhi. 2004 Jul;40(7):459-64. Zhonghua Yan Ke Za Zhi. 2004. PMID: 15454060 Chinese.
-
Pharmacologic vitreolysis in diabetic retinopathy.Curr Pharm Biotechnol. 2011 Mar 1;12(3):406-9. doi: 10.2174/138920111794480543. Curr Pharm Biotechnol. 2011. PMID: 20939804 Review.
-
Microplasmin-assisted vitrectomy.Dev Ophthalmol. 2009;44:26-30. doi: 10.1159/000223942. Epub 2009 Jun 3. Dev Ophthalmol. 2009. PMID: 19494649 Review.
Cited by
-
Pharmacologic vitreolysis.J Ophthalmic Vis Res. 2010 Jan;5(1):44-52. J Ophthalmic Vis Res. 2010. PMID: 22737326 Free PMC article.
-
Ocriplasmin for vitreoretinal diseases.J Biomed Biotechnol. 2012;2012:354979. doi: 10.1155/2012/354979. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23193358 Free PMC article. Review.
-
Rhegmatogenous retinal detachment following intravitreal ocriplasmin.Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2333-2338. doi: 10.1007/s00417-016-3398-7. Epub 2016 Jun 8. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27278373 Free PMC article.
-
CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism.J Neurosci. 2007 Apr 25;27(17):4499-506. doi: 10.1523/JNEUROSCI.0200-07.2007. J Neurosci. 2007. PMID: 17460063 Free PMC article.
-
Ocriplasmin for treatment of stage 2 macular holes: early clinical results.Ophthalmic Surg Lasers Imaging Retina. 2014 Jul-Aug;45(4):293-7. doi: 10.3928/23258160-20140709-05. Ophthalmic Surg Lasers Imaging Retina. 2014. PMID: 25037011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous